Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
Beteiligte Einrichtungen
Abstract
Newly discovered biomarkers ideally should prove clinical usefulness, provide additional detection, staging, and prognosis information to improve individual risk assessment, and potentially permit targeted cancer therapy.
Bibliografische Daten
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | 5 |
| ISSN | 0302-2838 |
| Status | Veröffentlicht - 2011 |
| pubmed | 21871709 |
|---|
